Clinical Trial Update: PD of VAY736 in Patients With Primary Sjögren's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update for VAY736 in patients with Primary Sjögren's Syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• VAY736

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Primary Sjögren's Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2019-02-12